S. Epstein

S. Epstein, Y. Ma, S. Popoff, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Role of Testosterone in Cyclosporine‐Induced Osteopenia

S. Epstein, Y. Ma, W. Jee, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A—Induced osteopenia in oophorectomized rats

S. Epstein, W. Jee, W. Jee, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Rapamycin: A bone sparing immunosuppressant?

S. Epstein, W. Jee, X. Liang, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone mineral metabolism in T lymphocyte–deficient and –replete strains of rat

G. Hendy, S. Epstein, W. Jee, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat.

S. Epstein, C. Liu, B. Rucinski, 1994, Metabolism: clinical and experimental.

Deranged bone mineral metabolism in chronic alcoholism.

S. Epstein, F. Ismail, S. Feitelberg, 1987, Metabolism: clinical and experimental.

Metabolic Bone Disease Following Organ Transplantation

T. Yuen, Li Sun, M. Zaidi, 2015 .

Parathyroids, bone and mineral metabolism

S. Epstein, D. Green, 2006 .

Modeling of Serum C‐Telopeptide Levels with Daily and Monthly Oral Ibandronate in Humans

M. Zaidi, S. Epstein, K. Friend, 2006, Annals of the New York Academy of Sciences.

The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat

S. Epstein, P. Jowell, M. Fallon, 2007, Calcified Tissue International.

INCREASING GROWTH WITH RAISED CIRCULATING SOMATOMEDIN BUT NORMAL IMMUNOASSAYABLE GROWTH HORMONE

A. Howell, S. Epstein, K. Hall, 1977, Clinical endocrinology.

bone-resorbing osteoclasts Evidence that calcineurin is required for the genesis of

P. Liu, M. Zaidi, Ling-Ling Zhu, 2016 .

Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts.

Li Sun, M. Zaidi, Ling-Ling Zhu, 2007, American journal of physiology. Renal physiology.

Amylin increases bone volume but cannot ameliorate diabetic osteopenia

S. Epstein, C. Liu, B. Rucinski, 2004, Calcified Tissue International.

Evaluation of bone mass and growth in young diabetics.

S. Epstein, P. Wiske, J. Norton, 1982, Metabolism: clinical and experimental.

CHAPTER 53 – Transplantation Osteoporosis

S. Epstein, 2008 .

Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus

S. Epstein, D. Holt, K. Rutault, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Chapter 52 – Transplantation Osteoporosis

S. Epstein, 2001 .

Questioning the association between bisphosphonates and atypical femoral fractures

T. Yuen, Li Sun, M. Zaidi, 2015, Annals of the New York Academy of Sciences.

Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy

S. Epstein, B. Hollis, P. Jowell, 2007, Calcified Tissue International.

T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.

S. Epstein, Y. Ma, W. Jee, 1996, Endocrinology.

A new function for CD38/ADP-ribosyl cyclase in nuclear Ca2+ homeostasis

Li Sun, M. Zaidi, A. Koval, 1999, Nature Cell Biology.

Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling.

S. Chakrabarti, S. Epstein, M. Fallon, 1988, Endocrinology.

The effects of muscle‐building exercise on Vitamin D and mineral metabolism

S. Epstein, N. Bell, D. Henry, 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evidence of a probable role for 25‐hydroxyvitamin D in the regulation of human calcium metabolism

S. Epstein, N. Bell, V. Greene, 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The influence of age on bone mineral regulating hormones.

B. Riggs, C. Johnston, S. Epstein, 1986, Bone.

Basic science and clinical utility of biochemical markers of bone turnover--a Congress report.

R. Eastell, M. Seibel, S. Epstein, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Organ transplantation and osteoporosis.

J. Bilezikian, S. Epstein, E. Shane, 1995, Current opinion in rheumatology.

Pentagastrin and glucagon stimulate serum somatostatin-like immunoreactivity in man.

S. Epstein, N. Bell, M. Berelowitz, 1980, The Journal of clinical endocrinology and metabolism.

Nonsteroid Immune Modulators and Bone Disease

R. Tamler, S. Epstein, 2006, Annals of the New York Academy of Sciences.

Transplantation Bone Disease Induced by Non-Steroid Immunosuppressants

M. Zaidi, S. Epstein, A. Inzerillo, 2005 .

Nonsteroid immunosuppressive agents and bone

S. Epstein, A. Inzerillo, 2004 .

Molecular and Functional Evidence for Calcineurin-A α and β Isoforms in the Osteoclast: Novel Insights into Cyclosporin A Action on Bone Resorption

M. Zaidi, A. Koval, S. Epstein, 1999 .

Normal vitamin D and mineral metabolism in essential hypertension.

S. Epstein, G. S. Hughes, H. Margolius, 1988, The American journal of the medical sciences.

Post‐transplantation bone disease: The role of immunosuppressive agents and the skeleton

S. Epstein, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The fate of bone after renal transplantation

S. Epstein, I. R. Dissanayake, 1998, Current opinion in nephrology and hypertension.

Increases in immunoreactive parathyroid hormone with age.

S. Epstein, P. Wiske, N. Bell, 1979, The New England journal of medicine.

Mechanisms of Immunosupressant-Induced Bone Disease

S. Epstein, G. R. Goodman, G. Goodman, 1998 .

Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years.

R. Mazess, R. Love, H. Barden, 1994, Archives of internal medicine.

The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat.

S. Epstein, M. Fallon, C. Movsowitz, 1989, Endocrinology.

Is cortical bone hip? What determines cortical bone properties?

S. Epstein, 2007, Bone.

The lack of adrenergic effect on somatostatin-like immunoreactivity in normal man

S. Epstein, M. Berelowitz, 1981, Neuropeptides.

Cytokines and osteoporosis

S. Epstein, W. Khovidhunkit, Solomon Epstein, 1997 .

Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the rat.

S. Epstein, Y. Ma, W. Jee, 1998, Transplantation.

Perspectives: Posttransplantation bone disease

S. Epstein, Ian A. Katz, 1992 .

Posttransplantation bone disease.

S. Epstein, I. Katz, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Somatostatin-like immunoreactivity in transplantable medullary carcinoma of rat thyroid: partial chromatographic and biological characterization.

L. Frohman, S. Epstein, N. Bell, 1980, Endocrinology.

Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats

S. Epstein, J. Tamasi, Y. Kharode, 1993, Calcified Tissue International.

The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.

S. Epstein, Y. Ma, W. Jee, 1994, Transplantation.

Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone

S. Epstein, M. Fallon, Stephen J Thomas, 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse.

J. Adams, S. Epstein, B. Halloran, 1991, Endocrinology.

Bone-derived proteins

S. Epstein, 1989, Trends in Endocrinology & Metabolism.

Evidence for alteration of the vitamin D-endocrine system in obese subjects.

S. Epstein, N. Bell, J. Shary, 1985, The Journal of clinical investigation.

Ibandronate: A Clinical Pharmacological and Pharmacokinetic Update

F. Bauss, S. Epstein, E. Worth, 2004, Journal of clinical pharmacology.

Evidence for abnormal regulation of circulating 1α,25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism

S. Epstein, R. Turner, N. Bell, 1984, Calcified Tissue International.

Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema. Diabetes Care 2016;39:179–186

S. Grant, B. Corkey, S. Epstein, 2016, Diabetes Care.

The effect of chronic caffeine administration on serum markers of bone mineral metabolism and bone histomorphometry in the rat

S. Epstein, P. Jowell, M. Fallon, 1988, Calcified Tissue International.

1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry.

S. Epstein, P. Jowell, M. Fallon, 1987, Endocrinology.

FAILURE OF ADRENERGIC α AND β RECEPTOR BLOCKADE TO ELEVATE THE TSH AND PROLACTIN RESPONSE TO TRH IN HYPERTHYROIDISM

S. Epstein, A. Vinik, B. Pimstone, 1975 .

Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.

S. Epstein, J. Poser, H. Traberg, 1985, The Journal of clinical endocrinology and metabolism.

Immunosuppressant drugs and bone disease: a clinician's perspective.

S. Epstein, 1998, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Somatostatin and serum gastrin in normal subjects and in patients with pernicious anaemia, chronic liver and renal disease.

D. Le Roith, S. Epstein, A. Vinik, 1975, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Bone and mineral status of patients beginning total parenteral nutrition.

S. Epstein, R. McClintock, H. Traberg, 1986, JPEN. Journal of parenteral and enteral nutrition.

Immunosuppressive therapy and the skeleton

E. Shane, S. Epstein, 1994, Trends in Endocrinology & Metabolism.

Molecular Effects of Calcineurin Inhibitors

M. Zaidi, S. Epstein, A. Schneider, 2005 .

AzaThioprine alone is bone sparing and does not alter cyclosporin A‐induced osteopenia in the rat

S. Epstein, G. Mann, B. Rucinski, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Radioactive iodine (131I) therapy for thyrotoxicosis at Groote Schuur Hospital over a 6-year period.

S. Epstein, J. Sagel, W. van Mieghem, 1972, Postgraduate medical journal.

17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.

S. Epstein, B. Stein, M. Takizawa, 1992, Endocrinology.

Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption

S. Epstein, M. Fallon, C. Movsowitz, 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comments on “Cyclosporin does not affect the absolute rate of cortical bone resportion at the organ level in the growing rat”

S. Epstein, Y. Ma, W. Jee, 1995, Calcified Tissue International.

The effect of a new vitamin D analog, 22-oxa-1α,25(OH)2D3, on bone mineral metabolism in normal male rats

S. Epstein, M. Fallon, B. Stein, 1992, Calcified Tissue International.

A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca 2 (cid:1) signaling via CD38/ADP-ribosyl cyclase, a putative intracellular NAD (cid:1) sensor

Li Sun, M. Zaidi, A. Koval, 2002 .

Cyclosporin a: Friend or foe?

S. Epstein, 1991, Calcified Tissue International.

Menstrual Disturbances in Chronic Renal Failure

J. Morley, S. Epstein, J. Sagel, 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Long term administration of prostaglandin inhibitors in vivo fail to influence cartilage and bone mineral metabolism in the rat.

S. Epstein, M. Fallon, F. Ismail, 1988, Bone and mineral.

Metabolic Bone Disease in the Post-transplant Population: Preventative and Therapeutic Measures.

S. Epstein, J. Nel, 2016, The Medical clinics of North America.

Thrombolysin therapy in myocardial infarction.

S. Epstein, A. Nassar, G. Katabi, 1962, The American journal of cardiology.

Demonstration of reduced mitogenic and osteoinductive activities in demineralized allogeneic bone matrix from vitamin D-deficient rats.

S. Epstein, R. Turner, N. Bell, 1988, The Journal of clinical investigation.

The Problem of Low Levels of Vitamin D and Osteoporosis

S. Epstein, 2006, Drugs & aging.

Effect of single large doses of oral calcium on serum calcium levels in the young and the elderly.

S. Epstein, J. Sagel, W. van Mieghem, 1973, Metabolism: clinical and experimental.

Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety.

P. Delmas, S. Epstein, R. Schimmer, 2006, Maturitas.

Serum and urinary markers of bone remodeling: assessment of bone turnover.

S. Epstein, 1988, Endocrine reviews.

A Unified Pathophysiological Construct of Diabetes and its Complications

S. Grant, B. Corkey, S. Epstein, 2017, Trends in Endocrinology & Metabolism.

Blocking FSH induces thermogenic adipose tissue and reduces body fat

T. Yuen, S. Izadmehr, Z. Bian, 2017, Nature.

Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration.

S. Epstein, M. Fallon, M Fallon, 1988, Endocrinology.

Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the rat.

S. Epstein, Y. Ma, W. Jee, 1999, Bone.

Radioactive iodine (1311) therapy forthyrotoxicosis at Groote Schuur Hospital overa6-year period

S. Epstein, J. Sagel, J. Kalk, 1972 .

Importance of psychosocial and behavioral factors in food ingestion in the elderly and their ramifications on oral health.

S. Epstein, 1987, Gerodontics.

Influence of estrogen deficiency and replacement on T-cell populations in rat lymphoid tissues and organs

S. Epstein, S. Popoff, F. Safadi, 2000, Endocrine.

Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption.

M. Zaidi, A. Koval, S. Epstein, 1999, Biochemical and biophysical research communications.

Lack of influence of isoproterenol, propranolol, and dopamine on immunoreactive parathyroid hormone and calcitonin in normal man

S. Epstein, N. Bell, H. Heath, 2006, Calcified Tissue International.

Cd38/Adp-Ribosyl Cyclase: A New Role in the Regulation of Osteoclastic Bone Resorption

Li Sun, M. Zaidi, S. Epstein, 1999 .

A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+ signaling via CD38/ADP‐ribosyl cyclase, a putative intracellular NAD+ sensor

Li Sun, M. Zaidi, A. Koval, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Cd38/Adp-Ribosyl Cyclase

Li Sun, M. Zaidi, S. Epstein, 1999, The Journal of cell biology.

Secondary osteoporosis: pathophysiology & diagnosis.

S. Epstein, Gregory R. Emkey, 2014, Best practice & research. Clinical endocrinology & metabolism.

Best Practice & Research Clinical Endocrinology & Metabolism

S. Epstein, Gregory R. Emkey, René Rizzoli, 2014 .

Bisphosphonates inactivate human EGFRs to exert antitumor actions

T. Yuen, M. Sgobba, A. Zallone, 2014, Proceedings of the National Academy of Sciences.

Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer

Ling-Ling Zhu, Yaoting Ji, Maria I. New, 2014, Proceedings of the National Academy of Sciences.

Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat.

S. Epstein, M. Fallon, T. Reinhardt, 1988, Endocrinology.

Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition

S. Epstein, N. Napoli, P. Pozzilli, 2016, Osteoporosis International.

Clinical, biochemical, radiographic, epidemiologic, and economic features of osteoporosis.

S. Epstein, C C Johnston, S Epstein, 1981, The Orthopedic clinics of North America.

Endocrine function in sclerosteosis.

P. Beighton, S. Epstein, H. Hamersma, 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.

S. Epstein, Y. Ma, W. Jee, 1994, Endocrinology.

Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure.

D. Leroith, S. Epstein, B. Pimstone, 1977, The Journal of clinical endocrinology and metabolism.

The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy.

S. Epstein, 2005, Mayo Clinic proceedings.

The Cellular and Molecular Aspects of Immunosuppressant Osteoporosis

Li Sun, M. Zaidi, S. Epstein, 2003 .

Thyrotrophin Response to Intravenous Thyrotrophin-Releasing Hormone in Patients with Hepatic and Renal Disease

S. Epstein, B. Pimstone, S. Hendricks, 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Prostaglandin E2 alleviates cyclosporin a‐induced bone loss in the rat

S. Epstein, W. Jee, H. Ke, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Alteration of Vitamin D metabolism in mexican‐Americans

J. Dunn, S. Epstein, B. Hollis, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evidence that obesity does not influence the vitamin D‐endocrine system in blacks

S. Epstein, N. Bell, J. Shary, 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Molecular cloning, expression, and function of osteoclastic calcineurin Aα

Li Sun, M. Zaidi, S. Epstein, 2003 .

Evidence for alteration of the vitamin D-endocrine system in blacks.

S. Epstein, N. Bell, J. Shary, 1985, The Journal of clinical investigation.

Disorders Associated With Acute Rapid and Severe Bone Loss

M. Zaidi, S. Epstein, A. Inzerillo, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss

S. Silverman, X. Guo, C. Turner, 2009, Current osteoporosis reports.

Disappearance rates of plasma growth hormone after intravenous somatostatin in renal and liver disease.

D. Le Roith, S. Epstein, B. Pimstone, 1975, The Journal of clinical endocrinology and metabolism.

The response of circulating parameters of bone mineral metabolism to ethanol- and EDTA-induced hypocalcemia in the rat.

S. Epstein, P. Jowell, C. Movsowitz, 1990, Bone and Mineral.

Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.

D. Leroith, S. Epstein, C. Jerome, 1997, The Journal of clinical endocrinology and metabolism.

Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.

S. Epstein, Y. Ma, W. Jee, 1996, Bone.

Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg

E. McCloskey, S. Epstein, M. Jeglitsch, 2009, Current medical research and opinion.

Evaluating the antifracture efficacy of bisphosphonates.

M. Zaidi, S. Epstein, M. Pazianas, 2009, Reviews on recent clinical trials.

Update of current therapeutic options for the treatment of postmenopausal osteoporosis.

S. Epstein, 2006, Clinical therapeutics.

Postmenopausal osteoporosis: Fracture consequences and treatment efficacy vary by skeletal site

S. Epstein, 2000, Aging.

Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis

L. Avioli, S. Epstein, R. Pacifici, 2007, Calcified Tissue International.

Bone Mineral Metabolism at the Menopause: Determinants and Markers

S. Epstein, I. Katz, 1993 .

Alendronate prevents cyclosporin A-induced osteopenia in the rat.

S. Epstein, Y. Ma, W. Jee, 1997, Bone.

Influence of age on cyclosporin A‐induced alterations in bone mineral metabolism in the rat in vivo

S. Epstein, W. Jee, H. Ke, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Is treatment of early postmenopausal women with bisphosphonates justified?

S. Epstein, 2007, International journal of clinical practice.

Ibandronate treatment for osteoporosis: Rationale, preclinical and clinical development of extended dosing regimens

S. Epstein, 2006, Current osteoporosis reports.

The effects of intravenous and oral cimetidine in primary hyperparathyroidism.

S. Epstein, P. Wiske, J. Norton, 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.

S. Epstein, N. Bell, P. Stern, 1979, The New England journal of medicine.

Emerging concepts in the epidemiology, pathophysiology, and clinical care of osteoporosis across the menopausal transition.

T. Yuen, Li Sun, M. Zaidi, 2018, Matrix Biology.

Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study.

S. Epstein, M. Fallon, B. Stein, 1991, Transplantation.

Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children.

S. Epstein, N. Bell, P. Stern, 1981, The Journal of clinical investigation.

A new rapid and reproducible homologous immunoradiometric assay for amino-terminal parathyroid hormone in the rat

S. Epstein, G. Mann, B. Rucinski, 2004, Calcified Tissue International.

Progression of Efficacy with Ibandronate

M. Zaidi, S. Epstein, S. T. Harris, 2007, Annals of the New York Academy of Sciences.

Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat

S. Epstein, W. Jee, H. Ke, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Serum osteocalcin and bone mineral metabolism following successful renal transplantation.

S. Epstein, F. Ismail, S. Thomas, 1989, Clinical Nephrology.

Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Jacques P. Brown, T. Schnitzer, P. Delmas, 1998 .

Drug-Induced Bone Loss

S. Epstein, P. Tannirandorn, 2000, Osteoporosis International.

Cellular and Molecular Consequences of Calcineurin Aα Gene Deletion

Li Sun, M. Zaidi, Ling-Ling Zhu, 2007 .

The effect of dipeptidyl peptidase‐IV inhibition on bone in a mouse model of type 2 diabetes

D. Leroith, S. Yakar, S. Epstein, 2014, Diabetes/metabolism research and reviews.

Bisphosphonates inactivate human EGFRs to exert antitumor actions

T. Yuen, M. Sgobba, A. Zallone, 2014, Proceedings of the National Academy of Sciences.

The effect of different preparations of human growth hormone on plasma renin activity in normal males.

D. Le Roith, R. Rabkin, S. Epstein, 1976, The Journal of clinical endocrinology and metabolism.

Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.

S. Epstein, W. Lubbe, 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

1,25 dihydroxyvitamin D3 modifies cyclosporine-induced bone loss

S. Epstein, M. Fallon, C. Movsowitz, 1990, Calcified Tissue International.